Home4568 • TYO
add
Daiichi Sankyo Co Ltd
Previous close
¥4,483.00
Day range
¥4,433.00 - ¥4,501.00
Year range
¥3,805.00 - ¥6,257.00
Market cap
8.64T JPY
Avg Volume
5.09M
P/E ratio
33.89
Dividend yield
1.35%
Primary exchange
TYO
In the news
Financials
Income Statement
Revenue
Net income
(JPY) | Sep 2024info | Y/Y change |
---|---|---|
Revenue | 446.55B | 18.92% |
Operating expense | 254.60B | 10.82% |
Net income | 61.29B | 53.26% |
Net profit margin | 13.73 | 28.92% |
Earnings per share | — | — |
EBITDA | 110.60B | 69.06% |
Effective tax rate | 25.60% | — |
Balance Sheet
Total assets
Total liabilities
(JPY) | Sep 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 707.67B | 19.79% |
Total assets | 3.30T | 24.46% |
Total liabilities | 1.67T | 58.69% |
Total equity | 1.62T | — |
Shares outstanding | 1.90B | — |
Price to book | 5.24 | — |
Return on assets | 6.97% | — |
Return on capital | 13.24% | — |
Cash Flow
Net change in cash
(JPY) | Sep 2024info | Y/Y change |
---|---|---|
Net income | 61.29B | 53.26% |
Cash from operations | 33.49B | 284.55% |
Cash from investing | -10.87B | -108.72% |
Cash from financing | -78.62B | -75.67% |
Net change in cash | -97.59B | -237.26% |
Free cash flow | 53.27B | -46.31% |
About
Daiichi Sankyo Company, Limited is a global pharmaceutical company and the second-largest pharmaceutical company in Japan. It achieved JPY 1,278 billion in revenue in 2022. The company owns the American pharmaceutical company American Regent.
Daiichi Sankyo, Inc. began operating in the U.S. in 2006. It is the U.S. subsidiary of Daiichi Sankyo Company, Limited, and a member of the Daiichi Sankyo Group. The organization, which includes U.S. commercial operations and global clinical development, is headquartered in Basking Ridge, New Jersey.
Daiichi Sankyo Europe, GmbH, the European subsidiary, is headquartered in Munich, Germany. The organization is responsible for development and manufacturing for 12 European countries.
Daiichi Sankyo Company, Limited is a full member of the European Federation of Pharmaceutical Industries and Associations and of the International Federation of Pharmaceutical Manufacturers and Associations. Wikipedia
CEO
Founded
Sep 28, 2005
Headquarters
Website
Employees
18,726